111in-exendin
mAbexperimentalImaging agent
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2015 (NCT02541734)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Glucagon-like peptide 1 receptorRadiopharmaceutical
GLP1R radiopharmaceutical
Chemistry & pharmacology
- Multi-specific
- No
- Imaging
- 111-indium
Oral
No
Parenteral
No
Topical
No
Also known as
- 111in-exendin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04733508 | N/A | Nov 1, 2019 | Radboud University, University of Coimbra |
| NCT02541734 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2015 | Radboud University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Radboud University | Academic/Hospital | 2 | 2 | 2 | 2015 |
| University of Coimbra | Academic/Hospital | 1 | 0 | 1 | 2019 |
2 organizations
Page 1 / 1